
Metabolic
99% PurePopular
Retatrutide
Triple agonist peptide for metabolic research
Select size
$65.00/ 10mg
✓ View Certificate of Analysis (COA)
For research purposes only. Not for human consumption.
Mechanism of Action
A triple agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously — representing the next generation of metabolic research compounds.
How It Works
- 1
GLP-1 receptor activation enhances insulin secretion and satiety
- 2
GIP receptor activation improves insulin sensitivity and fat metabolism
- 3
Glucagon receptor activation increases energy expenditure and hepatic fat oxidation
- 4
Triple action produces metabolic effects exceeding dual agonists
Key Research Benefits
- Triple receptor agonism
- Next-gen metabolic research
- Enhanced efficacy over dual agonists
- Energy expenditure modulation
Retatrutide's triple-agonist mechanism represents the cutting edge of incretin-based metabolic research, with early trials showing unprecedented results.
